Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maximal Androgen Suppression in Localized Prostate Cancer
NCT00298155Phase 2Completed
- Sponsor
- University of Washington
- Start
- Jul 2006
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dutasteride, bicalutamide, ketoconazole in prostate cancer (PCa), sponsored by University of Washington. Started Jul 2006; status: completed.
02
Drugs
dutasteridebicalutamideketoconazole
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00298155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00298155.